Troy A. Ignelzi - Feb 9, 2023 Form 4 Insider Report for Karuna Therapeutics, Inc. (KRTX)

Role: Chief Financial Officer
Signature: /s/ Troy Ignelzi
Stock symbol: KRTX
Transactions as of: Feb 9, 2023
Transactions value $: $0
Form type: 4
Date filed: 2/13/2023, 03:39 PM
Previous filing: Jan 19, 2023
Next filing: Feb 23, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KRTX	Common Stock	Award	$0	+8.65K	+39.61%	$0.00	30.5K	Feb 9, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KRTX	Option (right to buy)	Award	$0	+17.4K		$0.00	17.4K	Feb 9, 2023	Common Stock	17.4K	$187.26	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Comprised of restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest annually in four 25% installments commencing on February 9, 2024, subject to continued service through such dates.
F2	25% of this option shall vest on February 9, 2024, and the remaining 75% shall vest in twelve equal three-month installments over the following three years, subject to continued service through such dates.